This is an educational intervention study testing the effects of decision aids in promoting patient participation in early stage prostate cancer treatment decision making. The purpose of this study is to compare patient-physician communication between patients who receive a DVD that models patient communication strategies vs. those who do not receive a DVD. All patients will also receive a written decision aid that describes treatment options for early stage prostate cancer. The Investigators hypothesize that the DVD will: * increase patients' perceptions of the importance of their preferences to their decision making * increase patients' perceptions of their intention to discuss their values and preferences with their urologists and radiation oncologists * increase patients' actual engagement with their physician during the clinical encounter * increase the concordance between patient decision making preferences and actual decision making outcomes * increase long term satisfaction with decision on type of treatment selected * increase patient satisfaction with their decision and the decision making process * influence patient perception of his physician (e.g., trust) and of the diagnosis visit
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Enrollment
564
The decision aid, "Discussing the Choice: Talking with your Doctor about Early Stage Prostate Cancer" is a DVD modeling patient communication strategies. The DVD includes vignettes with actors depicting patient-physician discussions of prostate cancer treatments. In these vignettes, the patient models communication strategies designed to facilitate patient activation.
A written decision aid entitled "Making the Choice: Deciding What to Do About Early Stage Prostate Cancer" that describes treatment options for early stage prostate cancer.
University of Michigan Health System
Ann Arbor, Michigan, United States
Self-efficacy for discussing preferences (intention)
14 item survey instrument
Time frame: Time 1 (baseline)
Self-efficacy for discussing preferences (intention)
14 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
Self-efficacy for discussing preferences (actual)
14 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
Preference for shared decision making
1 item survey instrument
Time frame: Time 1 (baseline)
Preference for shared decision making
1 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
Prostate cancer related knowledge
10 item survey instrument
Time frame: Time 1 (baseline)
Prostate cancer related knowledge
10 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
Prostate cancer related knowledge
12 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
Prostate cancer related anxiety
6 item survey instrument
Time frame: Time 1 (baseline)
Prostate cancer related anxiety
6 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
Prostate cancer related anxiety
6 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
Prostate cancer related anxiety
7 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
Treatment preference
1 item survey instrument
Time frame: Time 2 (post-intervention, an average of 3 days after Time 1 baseline)
Treatment decision
2 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
Treatment decision
2 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
Decisional regret
5 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
Preference for shared decision making
1 item survey instrument
Time frame: Time 3 (post-diagnosis, an average of 1 month after Time 1 baseline)
Preference for shared decision making
1 item survey instrument
Time frame: Time 4 (6 months post diagnosis)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.